A Randomized, Parallel Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with DFD-01 (betamethasone dipropionate) Spray, 0.05% in Adolescent Subjects with Moderate to Severe Plaque Psoriasis | Dartmouth-Hitchcock
Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Randomized, Parallel Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with DFD-01 (betamethasone dipropionate) Spray, 0.05% in Adolescent Subjects with Moderate to Severe Plaque Psoriasis
Principal Investigator (?)
Study Number
F16122
Summary
To evaluate the potential of DFD-01 (betamethasone dipropionate) Spray, 0.05% to suppress the hypothalamic-pituitary-adrenal (HPA) axis. 
Phase (?)
Phase III
Sponsor (?)
Contact

Daniel Ressler

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0